IPO Plus

₹1,533.4

▼ -41.26 -2.62%

06 Aug 2026

NSE Listed · Pharmaceuticals

Rubicon Research Limited (RUBICON)

Volume: 2,55,419Avg Vol 1W: 1,70,350Avg Vol 1M: 2,43,49552W Range:₹570.75₹1,589.7
NSE BSE www.rubicon.co.in AI Report
Key Ratios
Checked just now
Market Cap₹25,360 Cr
Current Price₹1,533.4
Previous Close₹1,574.66
High / Low (52w)₹1,589.7 / ₹570.75
Volume2,55,419
Avg Vol (1W)1,70,350
Avg Vol (1M)2,43,495
Stock P/E102.77
Book Value₹77.93
Dividend Yield10%
ROE19.14%
ROA10.6%
Revenue (TTM)—
Revenue Growth50.4%
Profit Margin14.07%
Total Debt₹64 Cr
Shares Outstanding17 Cr
Face Value₹1
EPS (TTM)₹14.92
P/B19.68
Debt / Equity0.24
50 DMA₹1,380.04
200 DMA—
Day change-2.62%
Price Chart
₹1,533.4▲ 144.09% · 1Y
₹1575₹5772.5Cr
2025-10-16
2026-08-06

20-day avg volume: 2.5L shares

Pros
  • Healthy return on equity of 19.1%.
  • Pays a dividend yield of 10.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 78% YoY.
  • Stock trades at a high P/E of 103.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹296 Cr₹313 Cr₹358 Cr₹352 Cr₹412 Cr₹476 Cr₹514 Cr
EBITDA₹56 Cr₹61 Cr₹63 Cr₹70 Cr₹83 Cr₹100 Cr₹109 Cr
Net Profit₹34 Cr₹38 Cr₹36 Cr₹43 Cr₹54 Cr₹73 Cr₹77 Cr
EPS———————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹245 Cr₹1,288 Cr₹301 Cr₹278 Cr₹336 Cr₹302 Cr₹390 Cr₹1,762 Cr
EBITDA₹58 Cr₹231 Cr₹65 Cr₹56 Cr₹71 Cr₹57 Cr₹100 Cr₹363 Cr
Net Profit₹38 Cr₹134 Cr₹40 Cr₹35 Cr₹46 Cr₹37 Cr₹70 Cr₹247 Cr
EPS—8.68—————15.31
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹430 Cr₹538 Cr₹560 Cr₹750 Cr₹1,109 Cr₹1,451 Cr₹2,327 Cr
Total Liabilities₹90 Cr₹164 Cr₹254 Cr₹463 Cr₹724 Cr₹910 Cr₹1,038 Cr
Equity₹341 Cr₹374 Cr₹305 Cr₹286 Cr₹385 Cr₹541 Cr₹1,289 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹32 Cr₹95 Cr₹-54 Cr₹-73 Cr₹39 Cr₹198 Cr₹314 Cr
Investing₹-84 Cr₹-46 Cr₹-55 Cr₹-34 Cr₹-69 Cr₹-65 Cr₹-410 Cr
Financing₹80 Cr₹52 Cr₹63 Cr₹123 Cr₹44 Cr₹-40 Cr₹283 Cr
Free Cash Flow₹-27 Cr₹24 Cr₹-109 Cr₹-117 Cr₹-17 Cr₹198 Cr₹314 Cr
Shareholding
Promoter 59.76% Institutions 16.95% Public 23.3%
Efficiency & Working Capital
ROCE22.6%
Interest Coverage6.3
Dividend Payout—
Debtor Days106 d
Inventory Days152 d
Payable Days79 d
Cash Conversion Cycle179 d
Working Capital Days258 d
Shareholding Details

As of 2026-06-30

Promoter59.8%
FII7.5%
DII9.4%
Institutions16.9%
Public23.3%
Promoter Pledge0%
No. of Shareholders43,254
Shareholding Pattern

Quarterly — figures in %. Latest 8 quarters.

PeriodJul 2024Jul 2024Sept 2025Oct 2025Oct 2025Dec 2025Mar 2026Jun 2026
Promoters84.2%84.2%60%60%60%60%59.9%59.8%
FIIs0%0%9.4%5.4%9.4%8%7.5%7.5%
DIIs15.8%0%10.5%10.5%10.5%9.4%10%9.4%
Public0%15.8%20.1%24.1%20.1%22.6%22.6%23.3%
Promoter Pledge0%0%0%0%0%0%0%0%
No. of Shareholders15151,05,3111,05,3111,05,31131,91433,73843,254
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
General Atlantic Singapore Rr Pte LtdShareholding of Promoter and Promoter Group35.8%5.93 Cr
Shivanand Shankar Mankekar HufPublic Shareholding13.5%2.24 Cr
Surabhi Parag SanchetiShareholding of Promoter and Promoter Group7.9%1.31 Cr
Sumant PilgaonkarShareholding of Promoter and Promoter Group7.9%1.31 Cr
Pratibha Sudhir PilgaonkarShareholding of Promoter and Promoter Group3.9%64,35,000
Sudhir D PilgaonkarShareholding of Promoter and Promoter Group3.9%64,35,000
Amansa Investments LtdPublic Shareholding3.1%51,60,278
Kotak Midcap FundPublic Shareholding2.9%47,11,435
Motilal Oswal Small Cap FundPublic Shareholding1.7%28,61,358
Fidelity Funds - India Focus FundPublic Shareholding1.4%23,50,854
Nomura Funds Ireland Public Limited Company- Nomura Funds Ireland - India Equity FundPublic Shareholding1.4%22,39,895
Bajaj Finserv Flexi Cap FundPublic Shareholding1.3%21,91,575
Narendra Narhar BorkarPublic Shareholding1.1%17,63,790
Terentia Venture PartnersShareholding of Promoter and Promoter Group0.3%5,10,000
Parag Suganchand SanchetiShareholding of Promoter and Promoter Group0%30,000
Prashant PilgaonkarShareholding of Promoter and Promoter Group0%0
Sheela Suganchand SanchetiShareholding of Promoter and Promoter Group0%0
Suganchand Gendulal SanchetiShareholding of Promoter and Promoter Group0%0
Ananya Parag SanchetiShareholding of Promoter and Promoter Group0%0
Ira Parag SanchetiShareholding of Promoter and Promoter Group0%0
Saloni PilgaonkarShareholding of Promoter and Promoter Group0%0
Kimaya Sumant PilgaonkarShareholding of Promoter and Promoter Group0%0
Kirit Vishanji GalaShareholding of Promoter and Promoter Group0%0
Rumie GalaShareholding of Promoter and Promoter Group0%0
Smeet GalaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
CHANGAVALLI VENKATChairman & Independent Directo2025
PRATIBHA SUDHIR PILGAONKARExecutive Director & MD2025
PARAG SUGANCHAND SANCHETIExecutive Director & CEO2025
Varun TalukdarNon Executive Director2025
Shantanu RastogiNon Executive Director2025
Anand AgarwalNon Executive Director2025
K G AnanthakrishnanIndependent Non Exe. Director2025
MILIND ANIL PATILIndependent Non Exe. Director2025
DEEPASHREE OMKAR TANKSALECompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Service₹22 Cr14.3%
Manufacturing₹132 Cr85.7%
In-house Reseach & Development₹0 Cr0%
Segments — Geography
RegionRevenueShare
India₹11 Cr1.3%
USA₹832 Cr97.4%
Others₹11 Cr1.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1241515
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-07Dividend (1.5/- per share)Final
dividend2026-08-07₹1.5 (150%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202584500134863
202558000058
2025410013459
Insider / Designated-Person Trades

21 recent disclosure(s)

Girish Subramaniam IyerDisposal · 10,000
Prakash ChandranDisposal · 20,000
Prakash Chandran— · 10,000
Prakash Chandran— · 20,000
Prakash ChandranRevoke · 20,000
Prakash ChandranRevoke · 20,000
Company Information
Incorporated1999
ChairmanCHANGAVALLI VENKAT
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.rubicon.co.in ↗

📍 Medone House B-75 Road No.33, Wagle Estate, Thane (West), Maharashtra, 400604

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

RSWM LimitedR Systems International Ltd.Rama Telecom LimitedRattanIndia Enterprises Ltd.RattanIndia Power LimitedRubfila International Ltd.Ruby MillsRuchi Infrastructure Ltd.Ruchira Papers LimitedRudra Global Infra Prod LimitedRulka Electricals LimitedRupa & Company Ltd.All “R” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App